BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. (BBOT) Net income 2023–2025
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. (BBOT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$134.0MFY2025 · since FY2023: -$41,692 → -$134.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$134.0M | -80.5% |
| FY2024 | -$74.3M | -178051.7% |
| FY2023 | -$41,692 | — |
Source: SEC XBRL filings · For reference only · Not investment advice